2020 | | Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures | 박해심, 신유섭, 예영민 |
2022 | | Immunoregulatory effects of Lactococcus lactis-derived extracellular vesicles in allergic asthma | 박해심, 신유섭, 최영우 |
2019 | | Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study | 박해심, 신유섭, 예영민 |
2022 | | Interactions of Nanoparticles with Macrophages and Feasibility of Drug Delivery for Asthma | 신유섭 |
2021 | | Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial | 신유섭 |
2023 | | KAAACI Guidelines for Allergen Immunotherapy | 남동호, 신유섭, 이영수 |
2022 | | Mono-n-butyl phthalate regulates nuclear factor erythroid 2–related factor 2 and nuclear factor kappa B pathway in an ovalbumin-induced asthma mouse model | 박해심, 신유섭, 유민숙 |
2022 | | Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and Asthma | 신유섭 |
2019 | | New phenotypes in hypersensitivity reactions to nonsteroidal anti-inflammatory drugs | 박해심, 신유섭, 이영수 |
2021 | | Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma | 박해심, 신유섭, 예영민, 최영우 |
2020 | | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea | 박해심, 신유섭, 예영민 |
2021 | | Pragmatic Randomized Controlled Trial for Stepping Down Asthma Controller Treatment in Patients Controlled with Low-Dose Inhaled Corticosteroid and Long-Acting β2-Agonist: Step-Down of Intervention and Grade in Moderate Asthma Study | 신유섭 |
2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2022 | | Recent Advances in Allergen-Specific Immunotherapy in Humans: A Systematic Review | 신유섭 |
2021 | | Risk factors predicting Severe Asthma exacerbations in adult asthmatics: A real-world clinical evidence | 박해심, 신유섭, 예영민 |
2021 | | S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma | 박해심, 신유섭, 최영우 |
2019 | | Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis | 남동호, 박해심, 신유섭, 예영민, 이소희 |
2022 | | Serum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients | 박해심, 신유섭, 최영우 |
2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Sputum antinuclear antibody serves as a biomarker for severe asthma | 박해심, 신유섭 |
2024 | | ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma | 박해심, 신유섭, 장재혁, 최영우 |
2021 | | The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma | 박해심, 신유섭 |
2023 | | The effect of apigenin, an aryl hydrocarbon receptor antagonist, in Phthalate-Exacerbated eosinophilic asthma model | 박해심, 신유섭 |
2024 | | The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse | 박해심, 신유섭 |
2022 | | The Role of Di(2-Ethylhexyl) Phthalate as an Exacerbating Factor in Chronic Spontaneous Urticaria | 박해심, 신유섭 |
2023 | | Tissue Inhibitor of Metalloproteinase-1 Enhances Eosinophilic Airway Inflammation in Severe Asthma | 박해심, 신유섭, 유민숙, 최영우 |